37 studies found for:    " February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" February 05, 2012":" March 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (37 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Medical Marijuana Use in HIV+ Patients: Probability Survey
Condition: HIV Positive
Intervention:
2 Recruiting Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
Conditions: HIV Positive;   Marijuana Smoking
Intervention:
3 Completed Fetal HIV Transmission Risk and Duration of Membrane Rupture
Conditions: Human Immunodeficiency Virus;   HIV
Intervention:
4 Recruiting Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Losartan;   Drug: Placebo
5 Unknown  A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Conditions: Anemia;   Intestinal Helminthiasis;   Intestinal Schistosomiasis;   Human Immunodeficiency Virus I Infection;   Hematologic Diseases;   Opportunistic Infections
Intervention: Drug: Praziquantel and Albendazole
6 Completed
Has Results
Intervention to Retain HIV-positive Patients in Medical Care
Condition: Primary Care Appointment Keeping
Interventions: Behavioral: Enhanced contact plus behavioral skills;   Behavioral: Enhanced contact only;   Behavioral: Standard of Care
7 Recruiting Assessing the Safety of Dapivirine Gel and Film Formulations
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Film;   Drug: Dapivirine Vaginal Gel
8 Recruiting Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
Condition: HIV Infections
Interventions: Drug: Dapivirine;   Other: Placebo
9 Active, not recruiting Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
Conditions: HCV Coinfection;   HIV Infection
Intervention: Drug: Nitazoxanide
10 Recruiting Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, emtricitabine, maraviroc;   Drug: Tenofovir, emtricitabine, lopinavir/r
11 Completed Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs
Condition: HIV Infection
Intervention: Drug: stop statin and switch to an antiretroviral drug with less impact on lipid metabolism
12 Terminated Mild Neurocognitive Disorder in HIV Infection of the Brain
Condition: HIV-Associated Cognitive Motor Complex
Intervention:
13 Unknown  Dolutegravir Expanded Access Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: dolutegravir
14 Not yet recruiting Testing and Linkage to Care for Injecting Drug Users in Kenya
Condition: HIV Infection
Intervention: Behavioral: Point of Care CD4 count and peer case management
15 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP Vaccine
16 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA009-00-VP;   Biological: Placebo vaccine
17 Not yet recruiting Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
Conditions: HIV;   Adolescent Behavior;   Gender
Interventions: Other: Male-Specific Intervention Package;   Other: Female-Specific Intervention Package;   Drug: Pre-Exposure Prophylaxis (Females);   Behavioral: Cash Transfer Cohort (Females)
18 Recruiting Improving Blood Safety and HIV Testing in Brazil
Conditions: HIV;   Herpes Simplex 2;   Hepatitis C;   Hepatitis B;   Chagas Disease
Interventions: Behavioral: HIV Counseling and Testing;   Behavioral: Blood Donation
19 Active, not recruiting Phase I/IIa Dose-escalation Clinical Study of VAC-3S
Condition: HIV-1 Infection
Interventions: Biological: VAC-3S;   Biological: Placebo
20 Completed Preference of Genetic Polymorphism and Pharmacokinetics
Condition: HIV
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years